Stable Integration of Transgenes Delivered by a Retrotransposon–Adenovirus Hybrid Vector
dc.contributor.author | Soifer, Harris | en_US |
dc.contributor.author | Higo, Collin | en_US |
dc.contributor.author | Kazazian, Haig H. | en_US |
dc.contributor.author | Moran, John V. | en_US |
dc.contributor.author | Mitani, Kohnosuke | en_US |
dc.contributor.author | Kasahara, Noriyuki | en_US |
dc.date.accessioned | 2009-07-10T18:59:50Z | |
dc.date.available | 2009-07-10T18:59:50Z | |
dc.date.issued | 2001-07-20 | en_US |
dc.identifier.citation | Soifer, Harris; Higo, Collin; Kazazian, Haig H.; Moran, John V.; Mitani, Kohnosuke; Kasahara, Noriyuki (2001). "Stable Integration of Transgenes Delivered by a Retrotransposon–Adenovirus Hybrid Vector." Human Gene Therapy 12(11): 1417-1428 <http://hdl.handle.net/2027.42/63154> | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/63154 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11485633&dopt=citation | en_US |
dc.description.abstract | Helper-dependent adenoviruses show great promise as gene delivery vectors. However, because they do not integrate into the host chromosome, transgene expression cannot be maintained indefinitely. To overcome these limitations, we have inserted an L1 retrotransposon/transgene element into a helper-dependent adenovirus to create a novel chimeric gene delivery vector. Efficient adenovirus-mediated delivery of the L1 element into cultured human cells results in subsequent retrotransposition and stable integration of the transgene. L1 retrotransposition frequency was found to correlate with increasing multiplicity of infection by the chimeric vector, and further retrotransposition from newly integrated elements was not observed on prolonged culture. Therefore, this vector, which utilizes components of low immunogenic potential, represents a novel two-stage gene delivery system capable of achieving high titers via the initial helper-dependent adenovirus stage and permanent transgene integration via the retrotransposition stage. | en_US |
dc.format.extent | 496945 bytes | |
dc.format.extent | 2489 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Mary Ann Liebert, Inc., publishers | en_US |
dc.title | Stable Integration of Transgenes Delivered by a Retrotransposon–Adenovirus Hybrid Vector | en_US |
dc.type | Article | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 11485633 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/63154/1/104303401750298571.pdf | |
dc.identifier.doi | doi:10.1089/104303401750298571 | en_US |
dc.identifier.source | Human Gene Therapy | en_US |
dc.identifier.source | Human Gene Therapy | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.